Search

everythinglearnresearchcommunity

for

Search:↓

Fire Needle Therapy may help bring back skin color in vitiligo by affecting cell growth signals.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Frontal Fibrosing Alopecia is a type of hair loss affecting mostly older women, with no agreed best treatment.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

Bio-nanovesicles could improve hair and skin regeneration by delivering important molecules to repair and heal.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Antiandrogen therapy for hidradenitis suppurativa lacks strong evidence and needs more research.

Genetic discoveries are key for understanding, diagnosing, and treating inherited hair and nail disorders.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

Anti-androgens might help reduce COVID-19 severity in men.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Adjuvants, diet changes, and laser therapy may improve male pattern hair loss.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Early diagnosis and treatment of Hidradenitis Suppurativa are important to prevent serious physical and mental effects.